Return to News

Practice News

Cancer Care Centers of South Texas MDS Center of Excellence and the MDS Foundation Present Patient-Caregiver Forum on August 4, 2010

Patients, Caregivers to Learn about New MDS Therapies, Treatment Options and Quality of Life Issues

The Cancer Care Centers of South Texas Myelodysplastic Syndromes Center of Excellence and the MDS Foundation invite patients and caregivers to a public forum that will present information about new therapies, treatment options and quality of life issues on Wednesday, August 4, 2010 at the Omni San Antonio Hotel. The forum is free of charge to all participants.  Roger M. Lyons, M.D., F.A.C.P., director of the Cancer Care Centers of South Texas MDS Center of Excellence, will speak.  Nationally recognized for his work, Dr. Lyons is leading multiple clinical trials for patients with MDS.  One of the clinical trials, which involves Vidaza®, has impacted treatment nationwide. As part of the program, attendees will be able to participate in a question-and-answer segment with Dr. Lyons.
 
Forum hours are 9:30 a.m. to 2 p.m.  Breakfast and lunch are included for participants and their guests, all free of charge.   The Omni San Antonio Hotel is located in The Colonnade at IH-10 West and Wurzbach.
 
Reservations are required for the MDS Patient-Caregiver Forum.  For more information and to RSVP, phone 1-888-MDS-0839. Individuals with MDS who would like more information on MDS clinical trials, may call Cancer Care Centers of South Texas at 210-595-5300.
 
Myelodysplastic syndromes (MDS) are a group of diseases in which bone marrow does not make enough healthy blood cells.  MDS affects people of all ages.   It is one of the most common blood disorders of those over 60 years of age.  Some patients have a history of exposure to chemotherapy or radiation, and MDS is increasing among older adults as more of them survive chemotherapy treatment.   No curative treatment exists for MDS with the exception of bone marrow transplantation.  Despite dramatic improvement in treatment, approximately 70 percent of all patients with MDS eventually succumb to the complications or progression due to acute myeloid leukemia.  
 
The Myelodysplastic Syndromes Foundation and the Cancer Care Centers of South Texas MDS Center of Excellence are working together to further worldwide research efforts, provide excellence in diagnosis, treatment and supportive care for patients, and to extend education about MDS not only to the hematology-oncology physician community, but to patients, caregivers, and the general public.